Citius Pharmaceuticals Future Growth

How is Citius Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

57.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:CTXR - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2025	179	86	N/A	N/A	1
9/30/2024	95	22	N/A	N/A	1
9/30/2023	N/A	-35	N/A	-29	2
9/30/2022	N/A	-34	-28	-28	N/A
6/30/2022	N/A	-31	-68	-28	N/A
3/31/2022	N/A	-29	-65	-25	N/A
12/31/2021	N/A	-26	-59	-19	N/A
9/30/2021	N/A	-25	-64	-24	N/A
6/30/2021	N/A	-24	-22	-22	N/A
3/31/2021	N/A	-21	-21	-21	N/A
12/31/2020	N/A	-21	-21	-21	N/A
9/30/2020	N/A	-18	-17	-17	N/A
6/30/2020	N/A	-17	-16	-16	N/A
3/31/2020	N/A	-17	-16	-16	N/A
12/31/2019	N/A	-16	-15	-15	N/A
9/30/2019	N/A	-16	-12	-12	N/A
6/30/2019	N/A	-15	-12	-12	N/A
3/31/2019	N/A	-12	-11	-11	N/A
12/31/2018	N/A	-13	-11	-11	N/A
9/30/2018	N/A	-13	-11	-11	N/A
6/30/2018	N/A	-13	-12	-12	N/A
3/31/2018	N/A	-13	-12	-12	N/A
12/31/2017	N/A	-11	-9	-9	N/A
9/30/2017	N/A	-10	-8	-8	N/A
6/30/2017	N/A	-10	-6	-6	N/A
3/31/2017	N/A	-11	-6	-6	N/A
12/31/2016	N/A	-9	-7	-7	N/A
9/30/2016	N/A	-8	-6	-6	N/A
6/30/2016	N/A	-7	N/A	-5	N/A

Earnings vs Savings Rate: CTXR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: CTXR is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CTXR is expected to become profitable in the next 3 years.

Revenue vs Market: CTXR is forecast to have no revenue next year.

High Growth Revenue: CTXR is forecast to have no revenue next year.

Future ROE: Insufficient data to determine if CTXR's Return on Equity is forecast to be high in 3 years time